IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows Post author: Post published:December 14, 2023 Post category:uncategorized The role of type-2 interferon (IFNγ) in antiviral immunity. You Might Also Like Inhalable nanotherapy can activate the immune system against checkpoint-resistant melanoma January 5, 2026 Artificial intelligence enhances safety and precision in pediatric anesthesia October 12, 2025 Antibiotic use before and during pregnancy linked to psychological distress April 1, 2026
Inhalable nanotherapy can activate the immune system against checkpoint-resistant melanoma January 5, 2026